📰 Abt News
Page 163 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
May 1, 2023
Hudock Inc. lifted its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 168.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,795 shares of the healthcare product maker’s stock after acquiring an additional 1,752 shares during the period. […]
May 1, 2023
My name e is joshua florence, and one thing i learned being a firefighter is plan ahead. you dont know what youre getting into, but the end of the day, you know you have a team behind yothat can help you. not having to worry abt the future makes it possible to make the present as best as it can be for . - i just got the new job! - oh my god, im so excited for you! - [narrator] if you are ready to advance your career, southern new hampshire university can help you get there. - [tanzania] southern...
April 30, 2023
Arcblock (ABT) traded 11.3% higher against the U.S. dollar during the one day period ending at 20:00 PM E.T. on April 29th. One Arcblock token can now be purchased for about $0.12 or 0.00000421 BTC on exchanges. During the last seven days, Arcblock has traded up 14.4% against the U.S. dollar. Arcblock has a total […]
April 30, 2023
Brooktree Capital Management lessened its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 41.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,246 shares of the healthcare product maker’s stock after selling 3,710 shares during the period. Abbott […]
April 30, 2023
Fort Pitt Capital Group LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 702,020 shares of the healthcare product maker’s stock after buying an additional 5,969 shares during the […]
April 30, 2023
First Pacific Advisors LP cut its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 26.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,800 shares of the healthcare product maker’s stock after selling 1,029 shares during the period. First Pacific Advisors […]
April 30, 2023
MTM Investment Management LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 2.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 6,300 shares of the healthcare product maker’s stock after selling 149 shares during the quarter. MTM Investment Management LLC’s holdings in Abbott Laboratories were worth $692,000 at the […]
April 30, 2023
Laurel Wealth Advisors LLC increased its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 3.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 47,128 shares of the healthcare product maker’s stock after purchasing an additional 1,595 shares during the period. Abbott Laboratories comprises about 1.2% […]
April 30, 2023
Summit Trail Advisors LLC trimmed its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,074 shares of the healthcare product maker’s stock after selling 341 shares during the quarter. […]
April 30, 2023
Horan Capital Advisors LLC. raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,335 shares of the healthcare product maker’s stock after acquiring an additional 100 shares during […]